Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage
AUTOR(ES)
Mizukami, Hiroki
FONTE
American Society for Clinical Investigation
RESUMO
Gaucher disease, the most common lysosomal storage disease, is caused by a deficiency of glucocerebrosidase resulting in the impairment of glucosylceramide degradation. The hallmark of the disease is the presence of the Gaucher cell, a macrophage containing much of the stored glucosylceramide found in tissues, which is believed to cause many of the clinical manifestations of the disease. We have developed adult mice carrying the Gaucher disease L444P point mutation in the glucocerebrosidase (Gba) gene and exhibiting a partial enzyme deficiency. The mutant mice demonstrate multisystem inflammation, including evidence of B cell hyperproliferation, an aspect of the disease found in some patients. However, the mutant mice do not accumulate large amounts of glucosylceramide or exhibit classic Gaucher cells in tissues.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=150961Documentos Relacionados
- L-glucosylceramide: synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro.
- β-Glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis
- Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation
- Normal Host Defense during Systemic Candidiasis in Mannose Receptor-Deficient Mice
- Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice
